New COVID-19 drug screening hub established in Scotland
Life Arc funds hub based at the University of Glasgow - News - PharmaTimes
by Lucy Parsons
www.pharmatimes.com/news/new_covid-19_drug_screening_hub_established_in_scotland_1360882Life Arc funds hub based at the University of Glasgow - News - PharmaTimes
by Lucy Parsons
www.pharmatimes.com/news/new_covid-19_drug_screening_hub_established_in_scotland_1360882CCS1477 has a novel mechanism of action compared to existing treatments - News - PharmaTimes
by Lucy Parsons
www.pharmatimes.com/news/icr_researchers_identify_potential_new_treatment_for_drug-resistant_prostate_cancer_1361101AZ is aiming for approval in adults with and without type 2 diabetes - News - PharmaTimes
by Lucy Parsons
www.pharmatimes.com/news/us_priority_review_for_farxiga_in_chronic_kidney_disease_1360788Submission supported by results from phase II CodeBreaK 100 study - News - PharmaTimes
by Lucy Parsons
www.pharmatimes.com/news/amgen_files_kras_inhibitor_sotorasib_with_ema_1360485New administration option for relapsing-remitting MS patients - News - PharmaTimes
by Lucy Parsons
www.pharmatimes.com/news/eu_authorises_intramuscular_administration_of_biogens_plegridy_for_ms_1360789Swiss pharma company to acquire biotech for $449m (€380m) - News - PharmaTimes
by Lucy Parsons
www.pharmatimes.com/news/roche_acquires_irish_biotech_firm_inflazome_1351035Treatment is approved for relapsed/refractory multiple myeloma - News - PharmaTimes
by Lucy Parsons
www.pharmatimes.com/news/sanofis_sarclisa_bags_nice_recommendation_1353389IgE blocker approved as an add-on treatment for adult patients - News - PharmaTimes
by Lucy Parsons
www.pharmatimes.com/news/roches_xolair_gets_us_nod_for_nasal_polyps_1358818Dupixent, Forxiga and Opdivo were also recommended for therapeutic extensions - News - PharmaTimes
by Lucy Parsons
www.pharmatimes.com/news/ten_medicines_backed_for_eu_approval_1353630British drugmaker confirmed review on Sunday - News - PharmaTimes
by Lucy Parsons
www.pharmatimes.com/news/uks_mhra_starts_rolling_review_of_azs_coronavirus_vaccine_1355933